Earnings call transcript: Westlake Chemical reports Q2 2025 net loss

Westlake Chemical Corporation (WLK) reported a Q2 2025 net loss of $12 million ($0.09/share) on $3 billion in net sales, with its stock remaining stable in after-hours trading despite a challenging quarter. The loss was primarily driven by soft global manufacturing and weak construction trends impacting its Performance and Essential Materials (PEM) segment, which posted $52 million in EBITDA, while the Housing and Infrastructure Products (HIP) segment delivered strong performance with $275 million in EBITDA. WLK is implementing aggressive cost reductions, targeting an additional $200 million by 2026, and forecasts HIP revenue between $4.2 billion and $4.4 billion for 2025 with a 20-22% EBITDA margin, signaling confidence in its long-term growth strategy and operational improvements amidst market headwinds.

Analysis

Westlake Chemical Corporation (WLK) reported a challenging second quarter for 2025, posting a net loss of $12 million on $3 billion in sales. This performance highlights a significant divergence between its two primary business segments. The Performance and Essential Materials (PEM) segment was heavily impacted by soft global manufacturing activity, weak construction trends, and significant production disruptions from planned and unplanned outages, which reduced EBITDA by approximately $110 million. PEM generated only $52 million in EBITDA on $1.8 billion in sales. In stark contrast, the Housing and Infrastructure Products (HIP) segment demonstrated considerable strength and resilience, delivering $275 million in EBITDA on $1.2 billion in sales, achieving a robust 24% margin. This strength is attributed to a balanced portfolio serving both new construction and repair/remodel markets, alongside growing demand for municipal water applications stimulated by the 2021 Infrastructure Act. Management is proactively addressing the PEM segment's underperformance with a three-pronged strategy: improving plant reliability, optimizing the manufacturing footprint by closing the loss-making Pernice epoxy facility (which was losing over $100 million annually), and targeting an additional $200 million in structural cost reductions by 2026. Despite a downward revision in full-year revenue guidance for HIP to the $4.2-$4.4 billion range, the company maintained its strong 20-22% EBITDA margin forecast, signaling confidence in its pricing power and product mix.

Key Decisions for Investors

• Investors should monitor the execution of the PEM segment's turnaround, focusing on improved plant operating rates in Q3 and progress toward the newly announced $200 million in structural cost savings by 2026.
• The robust performance and 24% EBITDA margin of the HIP segment provide a significant cash flow cushion, and its outlook remains positive due to US infrastructure spending, which may warrant a valuation premium for this part of the business.
• Consider the stock as a tale of two segments; a long position is a bet on management's ability to fix the challenged PEM segment while the stable HIP business limits downside risk.
• Key risks to track include persistent softness in global manufacturing, execution on cost-cutting targets, and potential tariff impacts on exports, although the company notes duty drawback mechanisms currently mitigate risks in key markets like Brazil.